Description: Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company was incorporated in 1996 and is headquartered in Chongqing, China.
Home Page: www.pharscin.com
No. 89, Middle Sec of Huangshan Ave
Chongqing,
401120
China
Phone:
86 23 6762 2999
Officers
| Name | Title |
|---|---|
| Ms. Xiaoying Liu | CEO, GM & Director |
| Mr. Yong Lu Hang | COO & Deputy GM |
| Mr. Lie Chun Chen | Chief Technology Officer |
| Mr. Yuxun Wang | Chief Scientific Officer & Deputy GM |
| Ms. Ying Wang | Deputy GM & Director |
| Ms. Xue Dan You | Deputy GM, Sec. of the Board & Non-Independent Director |
| Xu Jun | Securities Affairs Representative |
| Ms. Xiaoyan Peng | Financial Controller |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 105.4211 |
| Price-to-Book MRQ: | 7.025 |
| Price-to-Sales TTM: | 12.1773 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1467 |